Staff - Registered Nurse (RN) - Director of Nursing - $95K-145K per year Gentiva
- $95,000–$145,000 Per Year
| Location | Chesterbrook, PA |
At Avalo (ahh-vah'-low), we are 100% focused on developing treatments for immune-mediated inflammatory diseases with large unmet needs that affect millions worldwide. Our strategy is to develop medicines that target the IL-1 pathway, which is a central driver of the inflammatory process.
We share a commitment to teamwork, passion for science, and dedication to patients suffering from acute and chronic inflammatory disorders. Our collective expertise in discovery, development, and regulatory approvals is evidenced in our strong individual track records of advancing multiple therapeutic programs to successful commercialization.
Position Summary:
The Associate Director/Director of IT will be a key contributor in shaping and advancing Avalo's IT capabilities in a highly regulated biotech/pharmaceutical environment. This role combines strategic ownership with hands-on execution across infrastructure, cybersecurity, cloud services, digital workplace technologies, and business systems. The ideal candidate brings deep technical expertise in Microsoft 365 and digital workplace technologies, sound judgment, and the ability to partner effectively across scientific and corporate functions to deliver secure, scalable, and fit-for-purpose technology solutions that support business growth.
Essential Duties and Responsibilities:
Required Education and Experience:
Additional Skills, Knowledge, and/or Abilities:
Other Requirements:
About Avalo Therapeutics
Avalo Therapeutics is a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1 pathway for immune-mediated inflammatory diseases. Avalo is advancing its lead anti-IL-1 monoclonal antibody (mAb) drug candidate, abdakibart, into a phase 3 registrational program in hidradenitis suppurativa (HS), a chronic inflammatory skin condition that affects an estimated 1–4% of the population globally. Avalo is pursuing additional development opportunities in IL-1 driven indications. Avalo is also developing AVTX-010, a long-acting next-generation anti-IL-1 mAb. For more information about Avalo, please visit www.avalotx.com.
ATTENTION: External Agencies and Placement Firms
A member of the Avalo Human Resources Department will contact an agency directly if an open position is eligible to be sourced from an outside recruiting service. Avalo does not accept unsolicited resumes from employment agencies for any employment opportunity. All agencies/recruiters must have a written agreement/SOW in place with Avalo and prior to submitting any resume or CV.
All resumes must be submitted through the appropriate process. Any resumes submitted without an agreement and/or any resumes sent unsolicited through e-mail accounts of Avalo employees will be considered outside of the appropriate process, do not imply or create any obligation on our part, do not impart any restrictions on Avalo with respect to the hiring of any persons whose resumes are so submitted and are not eligible for placement fees.